1. A-to-I RNA editing modulates the pharmacology of neuronal ion channels and receptors.
- Author
-
Streit AK and Decher N
- Subjects
- Adenosine metabolism, Animals, Humans, Inosine metabolism, Ion Channels metabolism, Nervous System Diseases metabolism, Receptors, Cell Surface genetics, Receptors, Cell Surface metabolism, Adenosine genetics, Inosine genetics, Ion Channels genetics, Nervous System Diseases drug therapy, Nervous System Diseases genetics, Neurotransmitter Agents pharmacology, RNA Editing
- Abstract
The regulation of neuronal excitability is complex, as ion channels and neurotransmitter receptors are underlying a large variety of modulating effects. Alterations in the expression patterns of receptors or channel subunits as well as differential splicing contribute to the regulation of neuronal excitability. RNA editing is another and more recently explored mechanism to increase protein diversity, as the genomic recoding leads to new gene products with novel functional and pharmacological properties. In humans A-to-I RNA editing targets several neuronal receptors and channels, including GluR2/5/6 subunits, the Kv1.1 channel, and the 5-HT(2C) receptor. Our review summarizes that RNA editing of these proteins does not only change protein function, but also the pharmacology and presumably the drug therapy in human diseases.
- Published
- 2011
- Full Text
- View/download PDF